Pradžia › Virškinimo ligos › Texas
Virškinimo ligos klinikiniai tyrimai Texas
13 tyrimai dėl Virškinimo ligos ieško dalyvių vietose Texas.
Miestai Texas
- Houston8 tyrimai
- San Antonio5 tyrimai
- Tyler5 tyrimai
- Dallas4 tyrimai
- Austin4 tyrimai
- Lewisville4 tyrimai
- Fort Worth3 tyrimai
- El Paso3 tyrimai
- Amarillo3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06598943Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - West Texas, Amarillo
- Texas Oncology - Gulf Coast, Beaumont
- ir dar 27
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07222800Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Texas Liver Institute, San Antonio
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07654283Product Surveillance Registry
- Austin
- Dallas
- Fort Worth
- ir dar 6
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
- Baylor College of Medicine/Texas Children's Hospital, Austin
- Baylor College of Medicine / Texas Children's Hospital, Houston
Renkami dalyviai
Amžius nuo 7 iki 12 · Visoms lytims · Atnaujinta 2026-09-17 · NCT07222943A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ir dar 30
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ir dar 21
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06419374Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- University of Texas Health Science Center at Houston, Houston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07351071Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-10 · NCT07494318Evaluation of Hepato-Pancreato-Biliary
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-10 · NCT07565454GpCRC Pediatric Gastroparesis Registry 2
- Texas Tech University Health Science Center, El Paso
- Baylor College of Medicine/Texas Children's Hospital, Houston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 8 iki 25 · Visoms lytims · Atnaujinta 2026-04-03 · NCT05981300Gastroparesis Registry 4
- Texas Tech University Health Science Center (TTUHSC), El Paso
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-04-03 · NCT05846802Endoscopic Retrograde Cholangiopancreatography
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Renkami dalyviaiStebimasis tyrimas
Amžius 15 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT07490132Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.